MEDtalks
Senaste MEDtalk
ELCC 2026: First-Line Immunotherapy in High PD-L1 Lung Cancer
/ Andreas Ravn Andersen
ELCC 2026: First-Line I-O Therapy Extends OS/PFS in Metastatic SCLC
/ Giuseppe Luigi Banna
Identifying Neurogenic Orthostatic Hypotension in Polyneuropathy
/ Markus Hedin Fedder
ELCC 2026: Blood-Based ML for Lung Cancer Prediction
/ Cecilie Mondrup Jacobsen
ELCC 2026: Key Trial Updates in Lung Cancer
/ Bjørn Henning Grønberg
ELCC 2026: Methylated Circulating Tumor DNA in Lung Cancer
/ Sara Witting Christensen Wen
AD/PD 2026: Lipid Changes in Parkinson’s Disease
/ Céline Galvagnion
AD/PD 2026: Annual Care Costs in Alzheimer’s Disease and Dementia
/ Yohannes Mengistu Balcha
























